Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

The FDA approved Lynozyfic (linvoseltamab-gcpt) to treat adults with relapsed/refractory multiple myeloma who have received at least 4 prior lines of therapy.

At the Neurosurgery & Spine Group (NSG), based in Los Angeles, neurosurgeons Dr. Jared Ament and Dr. Amir Vokshoor have ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...

Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic ...

Head and neck cancers (HNCs) form a diverse group of malignant tumors originating in the upper aerodigestive tract, ranking ...